Arrest of Interproximal Caries Lesion With 38% Silver Diamine Fluoride Solution
1 other identifier
interventional
45
1 country
1
Brief Summary
This study was conducted to assess the efficacy of 38% Silver Diamine fluoride and compare it with 5% sodium fluoride varnish in arresting interproximal caries in primary molars at 12 months follow-up. Bitewing radiographs were taken to diagnose as well as to assess caries depth at follow up visits. Each bitewing was scored based on ICCMS radiographic criteria and was compared (follow-ups to baseline)to check for caries arrest. Interproximal caries included in this study, according to ICCMS criteria, were at stages- RA - caries limited to outer half of enamel RA2 - caries limited to the inner half of enamel RA3 - caries limited to outer third of dentine RA4 - caries limited to middle third of dentine
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3
Started Aug 2021
Shorter than P25 for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 2, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
November 8, 2022
CompletedFirst Submitted
Initial submission to the registry
November 12, 2022
CompletedFirst Posted
Study publicly available on registry
March 30, 2023
CompletedMarch 30, 2023
November 1, 2022
1 year
November 12, 2022
March 17, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Caries arrest
Assessment with bitewing radiographs based on ICCMS radiographic scoring system
12 months
Study Arms (2)
38% silver diamine fluoride
EXPERIMENTAL5% sodium fluoride varnish
ACTIVE COMPARATORInterventions
Silver diamine fluoride is a topical medication composed of 25% silver, 5% fluoride, 8% ammonia, and 62% Deionized water, used to treat and prevent dental caries and relieve dentinal hypersensitivity.
It is a topical application with an active ingredient of 5% sodium fluoride(22,600ppm fluoride).it prolongs the contact time between the fluoride and tooth surface and promotes remineralization and inhibits demineralization.
Eligibility Criteria
You may qualify if:
- Children aged 5 to 9 years.
- Presence of at least 2 primary molars with interproximal caries.
- Carious lesions of enamel or outer or middle third of dentin in primary molars, as assessed by bitewing radiographs with ICCMSTM scoring (RA1, RA2, RA3, RB4).
You may not qualify if:
- \. Presence of advanced carious lesions reaching inner third of dentin detected by bitewing radiographic examinations ICCMSTM (RC5, RC6).
- \. Children or adolescents that refuse to participate in the study or present negative behaviours.
- \. Teeth with premature hypermobility 5. Both physically and mentally disabled children
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Post graduate institute of dental sciences
Rohtak, Haryana, 124001, India
MeSH Terms
Interventions
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 12, 2022
First Posted
March 30, 2023
Study Start
August 1, 2021
Primary Completion
August 2, 2022
Study Completion
November 8, 2022
Last Updated
March 30, 2023
Record last verified: 2022-11